难治性、复发性儿童Sweet综合征中的碘化钾：给药与监测指南
Potassium iodide in refractory, recurrent pediatric Sweet syndrome: Guidance in dosing and monitoring.
作者信息
Tangtatco Jennifer Aileen Ang, Ho Nhung, Drucker Aaron, Forse Catherine
机构信息
Division of Pediatric Medicine, Section of Dermatology, Hospital for Sick Children, Toronto, ON, Canada.
Department of Pediatrics, University of Toronto, Toronto, ON, Canada.
出版信息
Pediatr Dermatol. 2018 Mar;35(2):271-273. doi: 10.1111/pde.13391. Epub 2018 Jan 4.
We describe a 5-month-old boy with clinical and histopathologic presentation of Sweet syndrome. He responded to systemic corticosteroids, with multiple flares on tapering; potassium iodide was added, which provided complete resolution of Sweet syndrome. Potassium iodide has been used in only a few cases, and no standard dosage has been established in children. We discuss calculation of a pediatric dosage for potassium iodide in Sweet syndrome.
我们描述了一名5个月大的男童，其临床表现和组织病理学表现符合Sweet综合征。他对全身用皮质类固醇有反应，但在逐渐减量时出现多次病情复发；加用碘化钾后，Sweet综合征完全缓解。碘化钾仅在少数病例中使用过，儿童中尚未确立标准剂量。我们讨论了Sweet综合征中碘化钾儿科剂量的计算方法。
Zotero 插件